Barclays Maintains Overweight on Humana, Raises Price Target to $582

Benzinga Newsdesk www.benzinga.com Positive 85.8%

Neg 0% Neu 0% Pos 85.8%

Barclays analyst Andrew Mok maintains Humana (NYSE:HUM) with a Overweight and raises the price target from $515 to $582.